Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

956
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
956
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

12
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
12
Disorders of Hemostasis01:24

Disorders of Hemostasis

963
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
963
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14
Disorders of Leukocytes01:27

Disorders of Leukocytes

965
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
965
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

The 2024 McDonald criteria for the diagnosis of multiple sclerosis: implications for clinical practice.

Practical neurology·2026
Same author

Spectral Unmixing to Reduce Refraction Effects in Feulgen-Stained Slides.

Sensors (Basel, Switzerland)·2026
Same author

Evaluating the potential of sNfL as a biomarker in MS management in the UK: insights from SUNLIT survey.

BMC neurology·2025
Same author

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2025
Same author

Approach to JCV testing with natalizumab biosimilar: a UK consensus statement.

Multiple sclerosis and related disorders·2025

相关实验视频

Updated: Jul 12, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.5K

霍乱和多细胞血病真实.

Catriona Gribbin1, Arshi Yasmin2, Paul Gallagher3

  • 1Department of Neurology, Institute of Neurological Sciences, Glasgow, UK catriona.gribbin2@nhs.scot.

Practical neurology
|October 27, 2023
PubMed
概括

多细胞血症可导致晚发性胆固醇,即使血细胞计数正常. 这种可治疗的疾病的早期诊断对于经历了新冠肺炎运动的患者至关重要.

科学领域:

  • 神经学 神经学
  • 血液学 血液学 血液学
  • 内部医学 内部医学

背景情况:

  • 胆是一种超运动运动障碍,其特点是不自发,不规则和无目的的运动.
  • 多细胞血病 (PV) 是一种骨髓增殖性瘤,其特征是红细胞质量增加,通常与血栓和出血并发症有关.
  • PV的神经表现可能会发生,但胆发病是一种不常见的表现,特别是当血红素和血红蛋白水平处于正常范围内时.

研究的目的:

  • 报告两例与多细胞血病相关的晚发性胆固醇病例.
  • 强调在对新发病胆固醇的差异诊断中考虑真多细胞血症的重要性,即使没有明显的多细胞血症.
  • 强调多细胞血病的可治疗性质,以及在适当的管理下神经改善的潜力.

主要方法:

  • 两名患者的病例报告显示,他们出现了新发病的慢性病变.
  • 对临床病史,神经学检查结果和实验室结果的审查,包括完整血清和血红素.
  • 诊断检查胆病的二次原因.

主要成果:

  • 两名患者患有胆固醇,血红素和血红蛋白水平在正常参考范围内.
  • 在这两名患者中,尽管红细胞数量没有升高,但多细胞血症的诊断得到了确认.
  • 在报告的病例中,多细胞血病的治疗导致了形运动的改善或解决.
关键词:
血液学 血液学 血液学运动障碍 运动障碍

更多相关视频

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.4K

相关实验视频

Last Updated: Jul 12, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.5K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.4K

结论:

  • 在对晚发性胆固醇的差异诊断中应考虑多细胞血症,无论血红素和血红蛋白水平如何.
  • 早期识别和治疗真多细胞血症可以预防严重的并发症,并可能逆转神经症状,如胆病.
  • 本次演讲强调了多细胞真血病的多样化,有时微妙的神经表现.